Mid-Atlantic · Prenatal Carrier Screening Test – Inherited
Prenatal Carrier Screening Test – Inherited in Washington DC
Below is a plain-language overview of the prenatal carrier screening test – inherited. This blood test screens for carrier status of three inherited conditions that can be passed to a child.
What this test is
This panel tests for carrier status of Spinal Muscular Atrophy (SMA), Fragile X Syndrome, and Cystic Fibrosis (CF). Being a carrier means you have a gene change for a condition but do not have the condition yourself. However, you could pass the gene change to your child.
What it measures
- Spinal Muscular Atrophy (SMA) Carrier Status — reflects the likelihood of carrying a gene change for SMA
- Fragile X Syndrome Carrier Status — reflects the likelihood of carrying a gene change for Fragile X
- Cystic Fibrosis (CF) Carrier Status — reflects the likelihood of carrying a gene change for CF
What the test involves
A sample is collected through a standard blood draw from a vein in your arm. The collected blood is then sent to the laboratory for analysis.
Why it is often ordered
Clinicians often order this test for individuals planning a pregnancy or who are currently pregnant. It helps assess the risk of having a child with certain genetic conditions.
Preparation
No specific preparation is usually needed for this test. You should follow any specific instructions provided by the laboratory collecting your sample.
How results are reported
Results are typically available within a few business days and will indicate if you are a carrier for any of the tested conditions. Reference ranges and interpretations can vary between laboratories.
Before you go
- Turnaround time
- Specific preparation instructions
- How results are delivered
Cities
Prenatal Carrier Screening Test – Inherited in Washington DC communities
Choose your city for local context and to request this test.